Before being discontinued, the P2X7 receptor blocker had cleared a master protocol study in chronic pain, though Eli Lilly ...

In a recent study, researchers have uncovered significant differences in how medical laboratories interpret diagnostic results for Lyme disease, underscoring the urgent need for harmonized standards ...

Trials-in-progress poster of ongoing pivotal Phase 3 trial of DNA-mediated immunotherapy accepted at both IGCS and ESMO Congress ...

CHICAGO -- Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...

After 23 years of follow-up, the European Randomized Study of Screening for Prostate Cancer (ERSPC) confirmed a 13% lower ...

James Chelnis, MD, FACS, is an ophthalmic plastic and reconstructive surgeon at Manhattan Face & Eye. At the 2025 American ...

Central Asia’s diet is characterized by a heavy reliance on red meat, bread, and dairy, staples that are often missing or ...

Highlights New analysis of ATH434-201 double blind trial strengthens efficacy signal at high dose levelPositive data from ATH434-202 open-label ...

Illume Fertility, a leading fertility practice in the tri-state area known for its award-winning medical team of expert physicians, patient-centered care, and advanced reproductive treatments enabling ...

It is necessary to balance rigorous clinical trials with real-world evidence (RWE) to show how data from everyday practice ...

Confluent is positioning itself as the "context layer for enterprise AI" with new capabilities that aim to solve the problem ...